skip to Main Content

8th international congress on coronary artery disease, from prevention to intervention, Prague, Czech Republic. Efficacy of switching to ezetimibe/simvastatin 10/20 mg versus rosuvastatin 20 mg in high-risk patients with/without metabolic syndrome.

Back To Top